Analyst Reco. West Pharmaceutical Services, Inc. BOERSE MUENCHEN

Equities

WPS

US9553061055

Market Closed - BOERSE MUENCHEN Other stock markets 01:13:48 27/06/2024 am IST			After market 01:30:02 am
305.3 ^EUR	+1.56%		303.2	-0.69%

13/06	West Pharmaceutical Services Insider Sold Shares Worth $595,404, According to a Recent SEC Filing	MT
04/06	Transcript : West Pharmaceutical Services, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 08:00 AM

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

West Pharmaceutical Services Insider Sold Shares Worth $595,404, According to a Recent SEC Filing	14/06	MT
West Pharmaceutical Services Insider Sold Shares Worth $24,199,050, According to a Recent SEC Filing	10/05	MT
UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating	26/04	MT
Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423	26/04	MT
Stephens Adjusts West Pharmaceutical Services Price Target to $420 From $400	25/04	MT
UBS Cuts West Pharmaceutical Services Price Target to $375 From $400, Maintains Neutral Rating	16/02	MT
Deutsche Bank Raises West Pharmaceutical Services Price Target to $355 From $350, Maintains Hold Rating	16/02	MT
ANALYST RECOMMENDATIONS : Coinbase, Fortinet, Nike, Chipotle, Nvidia...	16/02
KeyBanc Adjusts West Pharmaceutical Services Price Target to $470 From $440, Maintains Overweight Rating	13/02	MT
Jefferies Upgrades West Pharmaceutical Services to Buy From Hold, Adjusts Price Target to $536 From $323	07/02	MT
ANALYST RECOMMENDATIONS : Caterpillar, Eli Lilly, Intel, Meta, T-Mobile...	07/02
ANALYST RECOMMENDATIONS : Abbvie, Burberry, Chevron, Cisco, M&S...	16/11
Stephens Lowers Price Target on West Pharmaceutical Services to $390 From $420, Maintains Overweight Rating	27/23/27	MT
Deutsche Bank Cuts West Pharmaceutical Services Price Target to $350 From $360, Maintains Hold Rating	27/23/27	MT
Keybanc Adjusts Price Target on West Pharmaceutical Services to $440 From $415, Maintains Overweight Rating	30/23/30	MT
KeyBanc Adjusts West Pharmaceutical Services' Price Target to $415 From $385, Keeps Overweight Rating	21/23/21	MT
Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $360 From $290, Maintains Hold Rating	20/23/20	MT
Stephens Adjusts West Pharmaceutical Services' Price Target to $420 From $400, Keeps Overweight Rating	17/23/17	MT
UBS Adjusts Price Target on West Pharmaceutical Services to $400 From $365, Maintains Neutral Rating	10/23/10	MT
BofA Securities Upgrades West Pharmaceutical Services to Buy From Neutral, Raises Price Target to $405 From $390	16/23/16	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. West Pharmaceutical Services, Inc. BOERSE MUENCHEN

Equities

WPS

US9553061055

Analyst Reco.

Filters